Ketamine has been used as an anesthetic before surgeries for decades, but it can also be an option for those struggling with ...
The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...
A new clinic in Stratford is offering a nasal ketamine spray to treat mental health conditions. Experts say it’s an option ...
Medicaid in Wisconsin has expanded to cover ketamine infusions as of Jan. 1, sparking conversations about the nuances in type ...
Health Canada approved a prescription esketamine nasal spray called Spravato in 2020 to help with treatment-resistant depression. Brandi Martin, a nurse practitioner at NuVista, holds the device used ...
The FDA has approved Janssen’s antidepressant nasal spray Spravato ... The drug is the first ketamine-based medicine approved to treat depression. Ketamine has long been seen as a potential ...
"This provides further evidence for the use of esketamine nasal spray in this difficult-to-treat ... an intranasal formulation of racemic ketamine. At JPM Week 2025 in San Francisco, pharmaphorum ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...